QBS-10072-S

N/A

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameQBS-10072-S
Drug Alias NameQBS10072SQBS-10072-SQBS72SQBS-72-SQBS'72S +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-LAT1
TargetsL-type amino acid transporter 1
Therapy Area/IndicationsBrain metastasesSolid tumoursUrinary Bladder Neoplasms +[25] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesQuadriga Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesNantong Bencao Quadriga Medical Technology Co LtdCorden Pharma Latina SpaNantong Bencao Quadriga Medical Technology HK Ltd +[6] 
Inactive CompaniesN/A
Active IndicationsBrain metastasesSolid tumoursUrinary Bladder Neoplasms +[25] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A